Literature DB >> 4126253

Interaction of vinblastine, vincristine and colchicine with serum proteins.

D W Donigian, R J Owellen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4126253     DOI： 10.1016/0006-2952(73)90110-x

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN： 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  16 in total

1.  Binding of a new vinca alkaloid derivative, S12363, to human plasma proteins and platelets. Usefulness of an erythrocyte partitioning technique.

Authors:  S Urien; G Bastian; C Lucas; J P Bizzari; J P Tillement
Journal:  Invest New Drugs       Date:  1992-11       Impact factor: 3.850

2.  Direct photoaffinity labeling of tubulin with colchicine.

Authors:  J Wolff; L Knipling; H J Cahnmann; G Palumbo
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-01       Impact factor: 11.205

Review 3.  Stability of solutions of antineoplastic agents during preparation and storage for in vitro assays. III. Antimetabolites, tubulin-binding agents, platinum drugs, amsacrine, L-asparaginase, interferons, steroids and other miscellaneous antitumor agents.

Authors:  A G Bosanquet
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

4.  Effects of anticancer drugs on the metabolism of the anticancer drug 5,6-dimethylxanthenone-4-acetic (DMXAA) by human liver microsomes.

Authors:  S Zhou; R Chin; P Kestell; M D Tingle; J W Paxton
Journal:  Br J Clin Pharmacol       Date:  2001-08       Impact factor: 4.335

5.  Brain uptake and anticancer activities of vincristine and vinblastine are restricted by their low cerebrovascular permeability and binding to plasma constituents in rat.

Authors:  N H Greig; T T Soncrant; H U Shetty; S Momma; Q R Smith; S I Rapoport
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

6.  The protein binding of vinblastine in the serum of normal subjects and patients with Hodgkin's disease.

Authors:  W H Steele; D J King; H E Barber; G M Hawksworth; A A Dawson; J C Petrie
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

7.  Binding of vinblastine to recrystallized human alpha 1-acid glycoprotein.

Authors:  W H Steele; D J Haughton; H E Barber
Journal:  Cancer Chemother Pharmacol       Date:  1982-12       Impact factor: 3.333

8.  The effect of colchicine on human blood platelets under conditions of short-term incubation.

Authors:  A Ribbi-Jaffe; R Apitz-Castro
Journal:  Biochem J       Date:  1979-02-15       Impact factor: 3.857

Review 9.  Clinical pharmacokinetics of commonly used anticancer drugs.

Authors:  F M Balis; J S Holcenberg; W A Bleyer
Journal:  Clin Pharmacokinet       Date:  1983 May-Jun       Impact factor: 6.447

10.  Vinorelbine high-affinity binding to human platelets and lymphocytes: distribution in human blood.

Authors:  S Urien; F Brée; F Breillout; G Bastian; A Krikorian; J P Tillement
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.